Literature DB >> 10833442

Targeting a recombinant adenovirus vector to HCC cells using a bifunctional Fab-antibody conjugate.

S K Yoon1, L Mohr, C R O'Riordan, A Lachapelle, D Armentano, J R Wands.   

Abstract

We developed a specific adenoviral gene delivery system with monoclonal antibody (mAb) AF-20 that binds to a 180 kDa antigen highly expressed on human hepatocellular carcinoma (HCC) cells. A bifunctional Fab-antibody conjugate (2Hx-2-AF-20) was generated through AF-20 mAb crosslinkage to an anti-hexon antibody Fab fragment. Uptake of adenoviral particles and gene expression was examined in FOCUS HCC and NIH 3T3 cells by immunofluorescence; beta-galactosidase expression levels were determined following competitive inhibition of adenoviral CAR receptor by excess fibre knob protein. The chimeric complex was rapidly internalized at 37 degrees C, and enhanced levels of reporter gene expression was observed in AF-20 antigen positive HCC cells, but not in AF-20 antigen negative NIH 3T3 control cells. Targeting of recombinant adenoviral vectors to a tumor associated antigen by a bifunctional Fab-antibody conjugate is a promising approach to enhance specificity and efficiency of gene delivery to HCC. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833442     DOI: 10.1006/bbrc.2000.2788

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Selective gene therapy for prostate cancer cells using liposomes conjugated with IgM type monoclonal antibody against prostate-specific membrane antigen.

Authors:  Shusei Ikegami; Takushi Tadakuma; Kazuo Yamakami; Takeshi Ono; Satoshi Suzuki; Ichiro Yoshimura; Tomohiko Asano; Masamichi Hayakawa
Journal:  Hum Cell       Date:  2005-03       Impact factor: 4.174

2.  Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium.

Authors:  H Xia; B Anderson; Q Mao; B L Davidson
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Mutation of herpesvirus Saimiri ORF51 glycoprotein specifically targets infectivity to hepatocellular carcinoma cell lines.

Authors:  Susan J Turrell; Adrian Whitehouse
Journal:  J Biomed Biotechnol       Date:  2010-12-09

4.  Retargeting of viruses to generate oncolytic agents.

Authors:  M H Verheije; P J M Rottier
Journal:  Adv Virol       Date:  2011-11-14

5.  Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells.

Authors:  Shihai Liu; Qinwen Mao; Weifeng Zhang; Xiaojing Zheng; Ye Bian; Dongyang Wang; Huijin Li; Lihong Chai; Junli Zhao; Haibin Xia
Journal:  Biosci Rep       Date:  2009-04       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.